Patents by Inventor Chien-Ping Liang

Chien-Ping Liang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Atherosclerosis susceptibility gene locus 1(athsq1) and atherosclerosis susceptibility gene locus 2 (athsq2)
    Publication number: 20040267000
    Abstract: This invention provides isolated nucleic acids encoding mammalian membrane-bound and soluble LOX-1 receptors. The invention also provides methods of identifying agents that inhibit the activity of a mammalian LOX-1 receptor. This invention further provides methods of preventing or treating atherosclerosis, heart disease or stroke in a subject which comprise reducing the activity of membrane-bound LOX-1 receptor.
    Type: Application
    Filed: August 30, 2004
    Publication date: December 30, 2004
    Inventors: Alan R Tall, Carrie L. Welch, Chien-Ping Liang
  • Atherosclerosis susceptibility gene locus 1 (Athsq1) and atherosclerosis susceptibility gene locus 2 (Athsq2)
    Patent number: 6756228
    Abstract: This invention provides isolated nucleic acids encoding mammalian membrane-bound and soluble LOX-1 receptors. The invention also provides methods of identifying agents that inhibit the activity of a mammalian LOX-1 receptor. This invention further provides methods of preventing or treating atherosclerosis, heart disease or stroke in a subject which comprise reducing the activity of membrane-bound LOX-1 receptor.
    Type: Grant
    Filed: July 2, 2001
    Date of Patent: June 29, 2004
    Assignee: The Trustees of Columbia University in the City of New York
    Inventors: Alan R. Tall, Carrie L. Welch, Chien-Ping Liang
  • Atherosclerosis susceptibility gene locus 1 (Athsq1) and atherosclerosis susceptibility gene locus 2 (Athsq2)
    Publication number: 20030068673
    Abstract: This invention provides isolated nucleic acids encoding mammalian membrane-bound and soluble LOX-1 receptors. The invention also provides methods of identifying agents that inhibit the activity of a mammalian LOX-1 receptor. This invention further provides methods of preventing or treating atherosclerosis, heart disease or stroke in a subject which comprise reducing the activity of membrane-bound LOX-1 receptor.
    Type: Application
    Filed: July 2, 2001
    Publication date: April 10, 2003
    Inventors: Alan R. Tall, Carrie L. Welch, Chien-Ping Liang